| |
 |
- IVIG Supply Index
- Albumin Supply Index
- Open Market Pricing
- Reimbursement Rates
- Industry News
- Subscribe to BST Quarterly
- Subscribe to IG Living
- MyFluVaccine Orders
- Resources
|
|
|
 |
|
|
|
| |
FFF Enterprises
(800) 843-7477
|
|
 |
 |
|
|
 |
 |
|
 |
 |
|
 |
 |
|
 |
 |
In U.S., Peak Flu Season This Year Was Worse Than Last
More American adults reported having the flu in April this year than did so in the same month last year, the fifth consecutive month in which monthly flu reports exceeded those from last season. Flu reports peaked in February, which is typical, at 3.3%, higher than the 2.2% in the same month last year. Read the full article »
HCPCS Level II Drug Codes Updated July 1
Effective July 1, HCPCS Level II code J7184 will be directly replaced with Q2041 Injection, von Willebrand factor complex (human), Wilate, per 100 IU VWF RCo, which describes Wilate® for intravenous injection for spontaneous or trauma-induced bleeding in patients with von Willebrand Disease (VWD), a hereditary bleeding disorder. Read the full article » |
|
| |
| |
 |
|
| |
 |
|
| |
 |
| |
| |
| |
Spotlight on Gammaplex
Immune Globulin Intravenous (Human)
For IVIG treatment of PIDD patients, consider Gammaplex 5% liquid, made without sucrose, glucose or maltose. With low IgA, competitive infusion time and no refrigeration required, Gammaplex is a proven option for replacement therapy. Call (800) 843-7477 for more details about Gammaplex.
Pricing Promotion on Kogenate FS
Bayer's antihemophilic factor (recombinant) for the treatment of hemophilia A is specially priced at $0.60/IU while supplies last. Contact FFF’s Wow! Customer Care at (800) 843-7477 to place your order. |
| |
| |
| |
| Product |
Outpatient Hospital |
Physician's Office |
|
| Carimune NF |
61.817 |
62.406 |
| Flebogamma 5% & 10% DIF |
70.764 |
71.438 |
| Gammagard Liquid |
76.052 |
76.776 |
| Gammagard S/D |
61.817 |
62.406 |
| Gammaplex |
74.586* |
74.586 |
| Gamunex-C |
74.512 |
75.222 |
| Privigen |
69.567 |
70.230 |
|
*ASP + 6% (Medicare pass-through drug)
Rates per gram are effective April 1, 2011 through June 30, 2011 |
| |
| |
| |
From Science Daily
Study Evaluates Parents' Reluctance to Vaccinate Asthmatic Kids
more »
From CNBC
National Organization for Rare Disorders Presents CSL Behring With 2011 Corporate Award
more »
From Reuters
Bayer Starts Selling Quick-Release Aspirin
more »
From Vaccine News Daily
Gates Says 10 Million Deaths Can Be Prevented by 2020
more »
From Time
FDA Approves a New Drug To Treat HIV
more » |
|
|
| |
| |
|
|
| |
 |
|
|
|
